Pediatrics

ACIP provides recommendations on meningococcal vaccination

(HealthDay)—Routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for adolescents aged 11 to 12 years with a booster at age 16 years, according to a report published in the Sept. ...

Vaccination

New vaccine design reduces inflammation, enhances protection

Adjuvants are a key ingredient of many modern vaccines, working to unleash an immune response that helps protect the body from disease. Many scientists believe that adjuvants are they key to developing new kinds of vaccines ...

HIV & AIDS

The quest for an HIV vaccine

The UNAIDS estimates that 38 million people currently live with human immunodeficiency virus (HIV) infection. Combination antiretroviral treatment has had great success in saving lives but is also associated with numerous ...

HIV & AIDS

The search for an effective HIV vaccine continues

An HIV vaccine trial that started in 2016 in South Africa was halted in February 2020. The study sponsors made the call after interim results showed that the vaccine, known as HVTN 702, did not prevent HIV. This result was ...

Diseases, Conditions, Syndromes

Experimental HIV vaccine regimen ineffective in preventing HIV

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine. This ...

page 7 from 27